Amgen (AMGN) Deferred Taxes (2013 - 2026)

Amgen has reported Deferred Taxes for 14 years, with the latest figure at -$291.0 million in Q2 2026.

• On a quarterly basis, Deferred Taxes rose 31.04% year-over-year to -$291.0 million in Q2 2026; TTM through Jun 2026 was -$516.0 million, a 53.76% increase from a year earlier, with the FY2025 full-year figure at -$721.0 million, up 41.29% from the prior year.
• Deferred Taxes was -$291.0 million for Q2 2026 at Amgen, down from -$176.0 million in the prior quarter.
• The five-year high for Deferred Taxes was -$19.0 million in Q4 2025, with the low at -$623.0 million in Q4 2023.
• Average Deferred Taxes over 5 years is -$271.5 million, with a median of -$277.0 million recorded in 2022.
• The sharpest annual moves came in 2024 and 2025: Deferred Taxes slumped 718.37% in 2024, then soared 94.31% in 2025.
• Over 5 years, Deferred Taxes stood at -$351.0 million in 2022, then slumped by 77.49% to -$623.0 million in 2023, then surged by 46.39% to -$334.0 million in 2024, then jumped by 94.31% to -$19.0 million in 2025, then plunged by 1431.58% to -$291.0 million in 2026.
• The last three Deferred Taxes figures came in at -$291.0 million (Q2 2026), -$176.0 million (Q1 2026), and -$19.0 million (Q4 2025), per Business Quant data.